Yayın: Myasthenia gravis following IFN-alpha-2a treatment
dc.contributor.buuauthor | Bora, İbrahim | |
dc.contributor.buuauthor | Karlı, Necdet | |
dc.contributor.buuauthor | Bakar, Mustafa | |
dc.contributor.buuauthor | Zarifoğlu, Mehmet | |
dc.contributor.buuauthor | Turan, Faruk | |
dc.contributor.buuauthor | Oǧul, Erhan | |
dc.contributor.department | Tıp Fakültesi | |
dc.contributor.department | Nöroloji Ana Bilim Dalı | |
dc.contributor.scopusid | 6602914249 | |
dc.contributor.scopusid | 6506587942 | |
dc.contributor.scopusid | 26643051200 | |
dc.contributor.scopusid | 6603411305 | |
dc.contributor.scopusid | 17636734100 | |
dc.contributor.scopusid | 6603268541 | |
dc.date.accessioned | 2021-09-13T08:43:37Z | |
dc.date.available | 2021-09-13T08:43:37Z | |
dc.date.issued | 1997 | |
dc.identifier.citation | Bora, İ. vd. (1997). "Myasthenia gravis following IFN-alpha-2a treatment". European Neurology, 38(1), 68-68. | |
dc.identifier.endpage | 68 | |
dc.identifier.issn | 0014-3022 | |
dc.identifier.issue | 1 | |
dc.identifier.pubmed | 9252802 | |
dc.identifier.scopus | 2-s2.0-0030786546 | |
dc.identifier.startpage | 68 | |
dc.identifier.uri | https://doi.org/10.1159/000112905 | |
dc.identifier.uri | https://www.karger.com/Article/Abstract/112905 | |
dc.identifier.uri | http://hdl.handle.net/11452/21882 | |
dc.identifier.volume | 38 | |
dc.identifier.wos | A1997XL25900012 | |
dc.indexed.wos | SCIE | |
dc.language.iso | en | |
dc.publisher | Karger | |
dc.relation.journal | European Neurology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Neurosciences & neurology | |
dc.subject.emtree | Adult | |
dc.subject.emtree | Case report | |
dc.subject.emtree | Clinical feature | |
dc.subject.emtree | Human | |
dc.subject.emtree | Kidney carcinoma | |
dc.subject.emtree | Male | |
dc.subject.emtree | Motor unit potential | |
dc.subject.emtree | Myasthenia gravis | |
dc.subject.emtree | Myasthenia gravis | |
dc.subject.emtree | Neutropenia | |
dc.subject.emtree | Priority journal | |
dc.subject.mesh | Autoimmunity | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Interferon Alfa-2a | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle aged | |
dc.subject.mesh | Myasthenia Gravis | |
dc.subject.scopus | Myasthenia Gravis; Vecuronium; Muscle Weakness | |
dc.subject.wos | Clinical neurology | |
dc.subject.wos | Neurosciences | |
dc.title | Myasthenia gravis following IFN-alpha-2a treatment | |
dc.type | Article | |
dc.wos.quartile | Q3 | |
dspace.entity.type | Publication | |
local.contributor.department | Tıp Fakültesi/Nöroloji Ana Bilim Dalı | |
local.indexed.at | PubMed | |
local.indexed.at | WOS |
Dosyalar
Lisanslı seri
1 - 1 / 1